Cas:112405-99-9 4-Ethyl-1-phenyl-1,3-octanedione manufacturer & supplier

We serve Chemical Name:4-Ethyl-1-phenyl-1,3-octanedione CAS:112405-99-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

4-Ethyl-1-phenyl-1,3-octanedione

Chemical Name:4-Ethyl-1-phenyl-1,3-octanedione
CAS.NO:112405-99-9
Synonyms:1-phenyl-4-ethyl-1,3-octanedione;4-ethyl-1-phenyl-1,3-octadione;4-Ethyl-1-phenyl-1,3-octanedione;4-ethyl-1-phenyl-octane-1,3-dione;4-Aethyl-1-phenyl-octan-1,3-dion;1,3-Octanedione, 4-ethyl-1-phenyl-;1,3-Octanedione,4-ethyl-1-phenyl
Molecular Formula:C16H22O2
Molecular Weight:246.345
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:351.9±15.0 °C at 760 mmHg
Density:1.0±0.1 g/cm3
Index of Refraction:1.497
PSA:34.14000
Exact Mass:246.161987
LogP:5.52

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 1-phenyl-4-ethyl-1,3-octanedione chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1,3-Octanedione,4-ethyl-1-phenyl physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-phenyl-4-ethyl-1,3-octanedione Use and application,4-Aethyl-1-phenyl-octan-1,3-dion technical grade,usp/ep/jp grade.


Related News: Right now, midstage data for Roche-AC Immune’s anti-tau antibody semorinemab in moderate Alzheimer’s are expected later this year, but it has already failed a phase 2 study in mild disease. 4-Ethyl-1-phenyl-1,3-octanedione manufacturer The two trials studied similar patient populations, Tendler said, but VMP was an old standard of care that’s not really used today in the U.S. Still, Tendler believes the two regimens may both have roles to play based on each patient’s ability to tolerate them. Whichever cocktail physicians choose, the two phase 3 studies have confirmed the benefit of Darzalex in transplant-ineligible patients, he added. 4-Ethyl-1-phenyl-1,3-octanedione supplier Right now, midstage data for Roche-AC Immune’s anti-tau antibody semorinemab in moderate Alzheimer’s are expected later this year, but it has already failed a phase 2 study in mild disease. 4-Ethyl-1-phenyl-1,3-octanedione vendor Thank you for being open” about the diagnosis, NBC’s chief foreign affairs correspondent and anchor Andrea Mitchell wrote to Amanpour on Twitter. “It is so important and typical of how strong and brave you’ve always been. Courage and honesty is your trademark. You will beat this too. 4-Ethyl-1-phenyl-1,3-octanedione factory Thank you for being open” about the diagnosis, NBC’s chief foreign affairs correspondent and anchor Andrea Mitchell wrote to Amanpour on Twitter. “It is so important and typical of how strong and brave you’ve always been. Courage and honesty is your trademark. You will beat this too.